XLAB: Revenue up 111% to $14.8M; net loss widens, balance sheet strengthened after Nasdaq listing

XLAB reported a 111% revenue increase to $14.8M, driven by GPU-as-a-Service demand and partnerships. Net loss widened due to higher expenses, but the balance sheet improved post-Nasdaq listing.

Original reporting
Published Sep 28, 2026, 8:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 9:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
XLAB: Revenue up 111% to $14.8M; net loss widens, balance sheet strengthened after Nasdaq listing — source image
Decision brief

The 30-second read

$XLABBearishMed
01

Why it matters

The earnings release combines strong top‑line growth with a widening loss, creating a mixed signal for investors.

02

Market read

First‑time earnings disclosure for XLAB; may trigger short‑term price movement.

03

What to watch

Balance sheet strengthening post‑Nasdaq listing may improve liquidity and reduce financing risk.

Relevance 6/10Novelty 7/10Timing: after-hours

Background

Exascale Labs recently listed on Nasdaq, providing greater visibility and access to capital.

Company-level read

Ticker impact

$XLABBearishHigh confidence
Context

Exascale Labs reported Q3 revenue of $14.8M, up 111% YoY, but net loss widened, disclosed in a fresh SEC 8‑K filing.

Expected impact

likely downside pressure as investors weigh higher loss against revenue growth

Evidence & confidence

First‑time disclosure of results; loss expansion is a material negative catalyst for a micro‑cap.

Market effects

Highlights growing demand for GPU‑as‑a‑Service, may benefit peers in AI infrastructure.

Limited to US micro‑cap space; no broad regional effect.

Minimal; the story is company‑specific.

Counterpoint

Revenue growth could signal a breakout if the company secures additional contracts, offsetting short‑term loss concerns.

Key entities

  • Exascale Labs Holdings Inc.

    Micro‑cap AI infrastructure provider (ticker XLAB).

Related articles

$XLABHigh

XLAB Stock Surges On $8.2M NVIDIA GPU Server Contract

Exascale Labs Holdings Inc. (XLAB) stock rose 11.76% on news of an $8.2M contract to supply NVIDIA GPU servers to Sunon. The company's stock has been volatile, trading between $1.36 and $3.80 recently. XLAB reported $7.0M in revenue, negative profitability, and $2.75M in operating cash flow for the latest quarter. The contract represents a significant catalyst for the small-cap company, driving short-term momentum.

$XLABHigh

XLAB Stock Surges After $8.2M NVIDIA GPU Server Deal

Exascale Labs Holdings Inc. (XLAB) stock surged 22.97% after securing an $8.2M deal to supply NVIDIA GPU servers to Sunon. The company reported $7M revenue, negative equity, and positive free cash flow. Traders are monitoring XLAB's momentum following the contract announcement, with the stock trading in a high-volatility range.

$XLABHigh

XLAB Stock Surges After $8.2M NVIDIA Server Deal Disclosure

Exascale Labs Holdings Inc. (XLAB) stock rose 14.41% after announcing an $8.2M contract to supply NVIDIA GPU servers to Sunon. The company reported $7M in revenue, a price-to-sales ratio of 16.7, and significant losses. The deal is seen as a potential catalyst for growth, driving trader interest despite financial fragility.

$XLABMed

Exascale shares jump 73%: The cash test behind its GPU deal

Exascale Labs' shares surged 73% after disclosing an $8.208M deal to supply 96 Nvidia GPUs. The contract's payment, delivery, and profit milestones are key. The customer, Sunon Inc., agreed to a 30% down payment. Exascale reported $14.82M revenue in FY2026, with a 16.3% gross margin. The deal's impact on cash flow and profits remains uncertain.

$XLABMed

Exascale Labs Holdings Inc. Reports 111% Revenue Growth for Full Fiscal Year 2026 and Provides Business Update Following Successful Nasdaq Listing

Exascale Labs Holdings Inc. (XLAB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Exascale Labs Holdings Inc. Reports 111% Revenue Growth for Full Fiscal Year 2026 and Provides Business Update Following Successful Nasdaq Listing ● Fiscal year 2026 revenue increased 111% to $14.8 million, compared to $7.0 million in fiscal year 2025, driven by acce

$XLABHigh

Exascale Labs Holdings Inc. (XLAB): Completion of Acquisition or Disposition of Assets

Exascale Labs Holdings Inc. (XLAB) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction Capitalized terms used and not defined in this Exhibit shall have the meanings assigned to them in the Current Report on Form 8-K to which this Exhibit is attached. As previously disclosed, On